BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26572808)

  • 1. Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits.
    Zheng J; Li Q; Wang W; Wang Y; Fu X; Wang W; Fan L; Yan W
    Oncol Rep; 2016 Feb; 35(2):809-16. PubMed ID: 26572808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
    Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
    Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma.
    Xiang J; Luo F; Chen Y; Zhu F; Wang J
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):181-9. PubMed ID: 24361215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
    J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
    Zou Z; Zheng B; Li J; Lv X; Zhang H; Yu F; Kong L; Li Y; Yu M; Fang L; Liang B
    Biomed Pharmacother; 2018 Nov; 107():1286-1293. PubMed ID: 30257343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
    Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.
    Wang Y; Gao Z; Zhang D; Bo X; Wang Y; Wang J; Shen S; Liu H; Suo T; Pan H; Ai Z; Liu H
    Oncotarget; 2017 Feb; 8(9):15775-15788. PubMed ID: 28178656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coding-noncoding gene expression in intrahepatic cholangiocarcinoma.
    Wang J; Xie H; Ling Q; Lu D; Lv Z; Zhuang R; Liu Z; Wei X; Zhou L; Xu X; Zheng S
    Transl Res; 2016 Feb; 168():107-121. PubMed ID: 26297049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells.
    Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J
    Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
    Int J Oncol; 2013 Feb; 42(2):690-8. PubMed ID: 23254774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.
    Shi T; Gong J; Fujita K; Nishiyama N; Iwama H; Liu S; Nakahara M; Yoneyama H; Morishita A; Nonura T; Kobara H; Okano K; Suzuki Y; Masaki T
    Int J Oncol; 2021 Feb; 58(2):199-210. PubMed ID: 33491760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.
    Chen MY; Zhang H; Jiang JX; Sun CY; Yu C; Tian S
    Tumour Biol; 2016 Oct; 37(10):14173-14181. PubMed ID: 27542675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].
    Cao K; Sun L; Zhang Y; Wang T; Li H; Zuo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1234-1238. PubMed ID: 30377134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
    Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY
    Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.